Literature DB >> 84045

HLA-D region-associated determinants serve as targets for human cell-mediated lysis.

C Feighery, P Stastny.   

Abstract

Effector cells for cell-mediated lysis (CML) were generated by in vitro culture of lymphocytes from selected donors with X-irradiated cells from unrelated subjects who were HLA-D homozygous and matched to the responders for the antigens of the HLA-A and HLA-B regions. By using chromium labeled monocytes as target cells, cytotoxicity was found to correlate with presence of HLA-D region antigens matching those of the stimulating cells. Such CML reactions apparently directed at products of HLA-D, were inhibited by addition of unlabeled monocytes or B lymphocytes. These unlabeled cells had to be matched for HLA-D with the stimulating cells used to generate the effector populations. The results suggested that products of HLA-D, perhaps the DR antigens, were recognized by cytotoxic lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 84045      PMCID: PMC2184802          DOI: 10.1084/jem.149.2.485

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  22 in total

Review 1.  Epstein-Barr virus and nonhuman primates: natural and experimental infection.

Authors:  A Frank; W A Andiman; G Miller
Journal:  Adv Cancer Res       Date:  1976       Impact factor: 6.242

2.  Detection of human B lymphocyte alloantigens by complement fixation.

Authors:  J Colombani; M Colombani; H Dastot; M Reboul; L Degos
Journal:  Transplantation       Date:  1977-09       Impact factor: 4.939

3.  Cell mediated lympholysis in man. Occurrence of unexpected, HL-A (LA and FOUR) irrelevant lympholysis.

Authors:  T Kristensen; N Grunnet; F Kissmeyer-Nielsen
Journal:  Tissue Antigens       Date:  1974

4.  SD vs. LD antigens as targets for lymphocyte-mediated cytotoxicity: study of a family presenting a recombination event within the MHR.

Authors:  G D Bonnard; M Chappuis; A Glauser; W Mempel; P Baumann; H Grosse-Wilde; E D Albert
Journal:  Transplant Proc       Date:  1973-12       Impact factor: 1.066

5.  Lymphocyte activation and destruction in vitro in relation to MLC and HL-A.

Authors:  V P Eijsvoogel; R du Bois; C J Melief; W P Zeylemaker; L Raat-Koning; L de Groot-Kooy
Journal:  Transplant Proc       Date:  1973-09       Impact factor: 1.066

6.  Cell-mediated cell lysis in vitro: genetic control of killer cell production and target specificities in the mouse.

Authors:  M Nabholz; J Vives; H M Young; T Meo; V Miggiano; A Rijnbeek; D C Shreffler
Journal:  Eur J Immunol       Date:  1974-05       Impact factor: 5.532

7.  Cell mediated lympholysis in man after sensitization of effector lymphocytes through mixed leukocyte cultures.

Authors:  J Lightbody; D Bernoco; V C Miggiano; R Ceppellini
Journal:  G Batteriol Virol Immunol       Date:  1971 Sep-Dec

8.  Mixed lymphocyte cultures in rheumatoid arthritis.

Authors:  P Stastny
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

9.  Association of the B-cell alloantigen DRw4 with rheumatoid arthritis.

Authors:  P Stastny
Journal:  N Engl J Med       Date:  1978-04-20       Impact factor: 91.245

10.  Cell-mediated lympholysis. Importance of serologically defined H-2 regions.

Authors:  B J Alter; D J Schendel; M L Bach; F H Bach; J Klein; J H Stimpfling
Journal:  J Exp Med       Date:  1973-05-01       Impact factor: 14.307

View more
  26 in total

1.  Differential behavior of cytotoxic effector cells against HLA antigens in strong genetic linkage disequilibrium.

Authors:  S J Kim; F T Christiansen; D M Silver; B Dupont
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

2.  Differential recognition of the serologically defined HLA-A2 antigen by allogeneic cytotoxic T cells. I. Population studies.

Authors:  S Horai; J J van der Poel; E Goulmy
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

3.  Cell-mediated cytotoxicity against HLA-D-region products expressed in monocytes and B lymphocytes. IV. Characterization of effector cells using monoclonal antibodies against human T-cell subsets.

Authors:  E J Ball; P Stastny
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

4.  Two distinct phenotypes of HLA-DR-specific cytotoxic T-cell lines.

Authors:  N Flomenberg; E Duffy; K Naito; B Dupont
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

5.  Development and characterization of allospecific long-term human cytolytic T-cell lines.

Authors:  C S Reiss; M E Hemler; V H Englehard; J W Mier; J L Strominger; S J Burakoff
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

6.  Molecular characterization of two Ia-like antigens in marmoset.

Authors:  C Goujet-Zalc; A Faille; J L Teillaud; P Turmel; G Mahouy; D J Charron
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

7.  Long-term human cytolytic T-cell lines allospecific for HLA-DR6 antigen are OKT4+.

Authors:  A M Krensky; C S Reiss; J W Mier; J L Strominger; S J Burakoff
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

8.  Cell-mediated cytotoxicity against HLA-D-region products expressed in monocytes and B lymphocytes. II. HLA-A- or B-antigen compatibility is not required for HLA-D-region directed cytotoxicity.

Authors:  C F Feighery; P Stastny
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

9.  Cell-mediated cytotoxicity against HLA-D-region products expressed in monocytes and B lymphocytes. I. Blocking by Unlabelled cells and inhibition by antisera.

Authors:  C F Feighery; P Stastny
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

10.  Alloantigens expressed on a subset of unstimulated human T lymphocytes that generate suppressor function.

Authors:  J Okada; P Stastny
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.